Ethanol metabolism in heavy drinkers after massive and moderate alcohol intake. 1983

S Keiding, and N J Christensen, and S E Damgaard, and A Dejgård, and H L Iversen, and A Jacobsen, and S Johansen, and F Lundquist, and E Rubinstein, and K Winkler

Some alcoholics have a regular daily alcohol consumption of more than 100 g. In preliminary observations we had the impression that the claimed alcohol intake in such 'heavy drinkers' was higher than could be accounted for by the ethanol elimination rate as measured routinely at 10 mmol/l (0.5 g/l). We therefore measured the ethanol elimination rate at very high blood ethanol concentrations of 40-80 mmol/l (2-4 g/l) found in eight alcoholics following heavy alcohol intake by measuring the falling blood ethanol concentrations until being less than 1 mmol/l. The elimination rate, on average 83 mumol/min per 1 blood, was about 49% higher than the elimination rate measured at 10 mmol/l in the same subject, being on average 58 mumol/min per 1/blood (paired t-test, P less than 0.05). The elimination rate following the high initial ethanol concentrations remained high until the concentration was below 5 mmol/l. Calculations of elimination rates are based on a number of assumptions concerning the physiologic and metabolic conditions. We examined specifically if the concentration-time curves could be adequately described by assuming metabolism according to a Michaelis-Menten pathway with a low Km value (simulating alcoholdehydrogenase with Km 0.2 mmol/l) or by assuming metabolism by two pathways with an alternative high-Km pathway with Km about 10 mmol/l. It was not necessary, in the statistical analysis, to include an alternative high-Km pathway. On the other hand, the data does give room for up to 50% elimination via such alternative pathways. The elimination rate at the high concentrations corresponded roughly to the claimed daily alcohol intake; furthermore the measured elimination rate at the lower concentrations were similar to values in non-alcoholics.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D004837 Epinephrine The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS. Adrenaline,4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol,Adrenaline Acid Tartrate,Adrenaline Bitartrate,Adrenaline Hydrochloride,Epifrin,Epinephrine Acetate,Epinephrine Bitartrate,Epinephrine Hydrochloride,Epinephrine Hydrogen Tartrate,Epitrate,Lyophrin,Medihaler-Epi,Acetate, Epinephrine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000428 Alcohol Drinking Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking. Alcohol Consumption,Alcohol Intake,Drinking, Alcohol,Alcohol Drinking Habits,Alcohol Drinking Habit,Alcohol Intakes,Consumption, Alcohol,Drinking Habit, Alcohol,Habit, Alcohol Drinking,Habits, Alcohol Drinking,Intake, Alcohol
D000431 Ethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. Alcohol, Ethyl,Absolute Alcohol,Grain Alcohol,Alcohol, Absolute,Alcohol, Grain,Ethyl Alcohol
D000437 Alcoholism A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4) Alcohol Abuse,Alcoholic Intoxication, Chronic,Ethanol Abuse,Alcohol Addiction,Alcohol Dependence,Alcohol Use Disorder,Abuse, Alcohol,Abuse, Ethanol,Addiction, Alcohol,Alcohol Use Disorders,Chronic Alcoholic Intoxication,Dependence, Alcohol,Intoxication, Chronic Alcoholic,Use Disorders, Alcohol

Related Publications

S Keiding, and N J Christensen, and S E Damgaard, and A Dejgård, and H L Iversen, and A Jacobsen, and S Johansen, and F Lundquist, and E Rubinstein, and K Winkler
October 1994, Alcoholism, clinical and experimental research,
S Keiding, and N J Christensen, and S E Damgaard, and A Dejgård, and H L Iversen, and A Jacobsen, and S Johansen, and F Lundquist, and E Rubinstein, and K Winkler
March 2013, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors,
S Keiding, and N J Christensen, and S E Damgaard, and A Dejgård, and H L Iversen, and A Jacobsen, and S Johansen, and F Lundquist, and E Rubinstein, and K Winkler
March 1984, Clinical pharmacology and therapeutics,
S Keiding, and N J Christensen, and S E Damgaard, and A Dejgård, and H L Iversen, and A Jacobsen, and S Johansen, and F Lundquist, and E Rubinstein, and K Winkler
June 2000, Alcoholism, clinical and experimental research,
S Keiding, and N J Christensen, and S E Damgaard, and A Dejgård, and H L Iversen, and A Jacobsen, and S Johansen, and F Lundquist, and E Rubinstein, and K Winkler
January 1989, Alcohol (Fayetteville, N.Y.),
S Keiding, and N J Christensen, and S E Damgaard, and A Dejgård, and H L Iversen, and A Jacobsen, and S Johansen, and F Lundquist, and E Rubinstein, and K Winkler
April 2005, Alcoholism, clinical and experimental research,
S Keiding, and N J Christensen, and S E Damgaard, and A Dejgård, and H L Iversen, and A Jacobsen, and S Johansen, and F Lundquist, and E Rubinstein, and K Winkler
November 2012, Drug and alcohol dependence,
S Keiding, and N J Christensen, and S E Damgaard, and A Dejgård, and H L Iversen, and A Jacobsen, and S Johansen, and F Lundquist, and E Rubinstein, and K Winkler
January 2009, Alcohol and alcoholism (Oxford, Oxfordshire),
S Keiding, and N J Christensen, and S E Damgaard, and A Dejgård, and H L Iversen, and A Jacobsen, and S Johansen, and F Lundquist, and E Rubinstein, and K Winkler
May 2021, Alcoholism, clinical and experimental research,
S Keiding, and N J Christensen, and S E Damgaard, and A Dejgård, and H L Iversen, and A Jacobsen, and S Johansen, and F Lundquist, and E Rubinstein, and K Winkler
August 2007, Rinsho byori. The Japanese journal of clinical pathology,
Copied contents to your clipboard!